Publication dates

All regions

Breast Cancer Industry, July 2014 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, prostate cancer, more »


 
1-20 of about 7 900 reports for Breast Cancer

Breast Cancer Drug Pipeline Update 2014

Breast Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... In addition, there are 8 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 208 drugs. breast cancer drug pipeline update lists all drugs and gives you a progress ...

Breast Cancer Drug Pathway Analyzer 2014

Breast Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... To your pipeline specifications3. Compare - you can overlay any pathways with each other and do a comparative analysisyou can interactively analyze any breast cancer drug ...

Global Women%s Health Market 2014-2018

Global Women%s Health Market 2014-2018

  • $ 2 500
  • Industry report
  • July 2014
  • by Infiniti Research Limited

... And polycystic ovarian syndrome as well as urological disorders and cancers such as breast cancer, cervical cancer, endometrial cancer, and ovarian cancer. In addition, contraception plays an important role ...

 Hormone Refractory Breast Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Hormone Refractory Breast Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Reasons to buy - evaluate the marketing status and exclusivity details of hormone refractory breast cancer key products to exploit opportunities for generic drug development ...

 Metastatic Breast Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Metastatic Breast Cancer Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Evaluate the marketing status and exclusivity details of metastatic breast cancer key products to exploit opportunities for generic drug development opportunities. - Identify and understand important ...

Lapatinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Lapatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • July 2014
  • by Ark Patent Intelligence

... This report covers:international nonproprietary name: lapatinibindications: advanced or metastatic breast cancerinnovator:glaxosmithkline (tykerb, tycerb)country coverage ...

MetaStat, Inc. (MTST) - Product Pipeline Analysis, 2014 Update

MetaStat, Inc. (MTST) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Calc platform 18dec 17, 2013: metastat announces poster presentation at the 2013 san antonio breast cancer symposium 18nov 11, 2013: metastat announces notice of allowance for a u.S. Patent supporting ...

Becton, Dickinson and Company (BDX) - Product Pipeline Analysis, 2014 Update

Becton, Dickinson and Company (BDX) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Description 27diagenode enteric viral panel real time pcr kit - product status 28diagenode enteric viral panel real time pcr kit - product description 28diagnostic test - breast cancer - product ...

CytoCore, Inc. (CYOE) - Product Pipeline Analysis, 2014 Update

CytoCore, Inc. (CYOE) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Collection device and associated assays for detecting breast cancer risk; number of biomarker assays for the detection and diagnosis of cancer; and a next generation specialized system for computer supported ...

AnalizaDx, LLC - Product Pipeline Analysis, 2014 Update

AnalizaDx, LLC - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

... Products summary by development stage 9biomarker assay - breast cancer - product status 10biomarker assay - breast cancer - product description 10biomarker assay - colon cancer - product ...

About 4 700 reports for Breast Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Breast Cancer Statistics, 2013
  • January 2013
    11 pages
  • Breast Cancer  

    Cancer  

  • United States  

    North America  

View report >

3 Companies for Breast Cancer

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.